← Back to Clinical Trials
Recruiting NCT06655506

NCT06655506 Enhanced Recovery Protocols in Gynecologic Oncology

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06655506
Status Recruiting
Phase
Sponsor National and Kapodistrian University of Athens
Condition ERAS
Study Type OBSERVATIONAL
Enrollment 600 participants
Start Date 2024-10-20
Primary Completion 2026-03-31

Eligibility & Interventions

Sex Female only
Min Age 25 Years
Max Age 85 Years
Study Type OBSERVATIONAL
Interventions
ERAS groupControl group

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 600 participants in total. It began in 2024-10-20 with a primary completion date of 2026-03-31.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Enhanced Recovery After Surgery (ERAS) are developed to provide a systematic structure for managing postsurgical patients.These protocols promote evidenced-based practices and implement a multidisciplinary effort to maintain normal physiology in the perioperative period and aid in earlier recovery. The present study aims to investigate the feasibility of and compliance to a structured ERAS protocol among Gynecological Oncological Centers in Greece as well as to compare the outcomes among patients that fullfilled the minimum number of necessary criteria, compared to those that were enrolled in ERAS protocols but did not meet the sufficient necessary criteria.

Eligibility Criteria

Inclusion Criteria: patients with gynaecological cancer and an ECOG performance status \<4, ASA score \<4. Exclusion Criteria: patients with metastatic cancer of non-gynaecological origin patients that are not able to follow ERAS protocol due to medical reasons patients with severe debilitating comorbidities (ECOG status 4, ASA score 4-5)

Contact & Investigator

Central Contact

Nikolaos Thomakos, MD, PhD

✉ thomakir@hotmail.com

📞 +302132162291

Frequently Asked Questions

Who can join the NCT06655506 clinical trial?

This trial is open to female participants only, aged 25 Years or older, up to 85 Years, studying ERAS. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06655506 currently recruiting?

Yes, NCT06655506 is actively recruiting participants. Contact the research team at thomakir@hotmail.com for enrollment information.

Where is the NCT06655506 trial being conducted?

This trial is being conducted at Athens, Greece, Athens, Greece, Athens, Greece, Larissa, Greece and 4 additional locations.

Who is sponsoring the NCT06655506 clinical trial?

NCT06655506 is sponsored by National and Kapodistrian University of Athens. The trial plans to enroll 600 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology